Mark E. Labadia

2.0k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Mark E. Labadia is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mark E. Labadia has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Mark E. Labadia's work include Immune Response and Inflammation (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mark E. Labadia is often cited by papers focused on Immune Response and Inflammation (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Mark E. Labadia collaborates with scholars based in United States, Netherlands and France. Mark E. Labadia's co-authors include Ronald B. Faanes, Robert J. Eckner, John L. Sullivan, Joseph C. Wu, Susan E. Hattox, Alan S. Rosenthal, Karl D. Hargrave, Karl Grozinger, Vincent J. Merluzzi and Cheng-Kon Shih and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Mark E. Labadia

18 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1990 653 citations Vincent J. Merluzzi, Karl D. Hargrave et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Labadia United States	14	508	461	450	302	230	18	1.3k
Hidekazu Sawada Japan	11	271 0.5×	602 1.3×	480 1.1×	411 1.4×	106 0.5×	25	1.3k
Robert J. Eckner United States	17	721 1.4×	709 1.5×	674 1.5×	382 1.3×	249 1.1×	27	2.0k
Robert L. Simmer United States	19	372 0.7×	1.4k 3.0×	302 0.7×	168 0.6×	261 1.1×	25	2.3k
Himadri Samanta United States	19	298 0.6×	676 1.5×	268 0.6×	393 1.3×	69 0.3×	35	1.2k
Eduardo Pauls Spain	20	248 0.5×	437 0.9×	469 1.0×	409 1.4×	38 0.2×	36	1.1k
Yoshio Aramaki Japan	19	305 0.6×	624 1.4×	515 1.1×	377 1.2×	393 1.7×	22	1.6k
Russell K. Young United States	11	301 0.6×	533 1.2×	298 0.7×	125 0.4×	57 0.2×	11	1.3k
L Tuel-Ahlgren United States	25	222 0.4×	759 1.6×	162 0.4×	652 2.2×	169 0.7×	35	1.9k
Shiro Shibayama Japan	13	206 0.4×	310 0.7×	288 0.6×	662 2.2×	96 0.4×	26	1.2k
Lorraine Everitt United States	11	504 1.0×	680 1.5×	553 1.2×	70 0.2×	46 0.2×	12	1.3k

Countries citing papers authored by Mark E. Labadia

Since Specialization

Citations

This map shows the geographic impact of Mark E. Labadia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Labadia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Labadia more than expected).

Fields of papers citing papers by Mark E. Labadia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Labadia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Labadia. The network helps show where Mark E. Labadia may publish in the future.

Co-authorship network of co-authors of Mark E. Labadia

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Labadia. A scholar is included among the top collaborators of Mark E. Labadia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Labadia. Mark E. Labadia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Tok, Melissa N. van, Mohamed Mandour, Joseph Wahle, et al.. (2021). Paradoxical Augmentation of Experimental Spondyloarthritis by RORC Inhibition in HLA-B27 Transgenic Rats. Frontiers in Immunology. 12. 699987–699987. 3 indexed citations

Anderson, Marie, Delphine Collin, Ingo Muegge, et al.. (2017). Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors. Journal of Biological Chemistry. 292(28). 11618–11630. 42 indexed citations

Muegge, Ingo, Delphine Collin, B. Cook, et al.. (2015). Discovery of 1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide analogs as new RORC modulators. Bioorganic & Medicinal Chemistry Letters. 25(9). 1892–1895. 18 indexed citations

Slavin, Anthony, et al.. (2010). Pathogenic mechanisms and experimental models of multiple sclerosis. Autoimmunity. 43(7). 504–513. 39 indexed citations

Yang, Jianfei, Min Yang, Xinshou Ouyang, et al.. (2008). Epstein‐Barr virus‐induced gene 3 negatively regulates IL‐17, IL‐22 and RORγt. European Journal of Immunology. 38(5). 1204–1214. 84 indexed citations

Kroe‐Barrett, Rachel, Neil A. Farrow, Jerry L. Hopkins, et al.. (2007). Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor. Biophysical Chemistry. 128(2-3). 156–164. 17 indexed citations

Thomson, David, Raj Betageri, Ming‐Hong Hao, et al.. (2007). Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2465–2469. 10 indexed citations

Caviness, Gary, Mark E. Labadia, Patricia Giblin, et al.. (2007). The determination and correlation of molecular and cellular equilibrium Kd and kinetic koff values for small molecule allosteric antagonists of LFA-1. Biochemical Pharmacology. 74(1). 98–106. 3 indexed citations

White, Della, Xiang Li, Adedayo Hanidu, et al.. (2006). Involvement of GATA3 in Protein Kinase C θ‐induced Th2 cytokine expression. European Journal of Immunology. 36(12). 3305–3314. 27 indexed citations

10.

Lukas, Susan, Rachel Kroe‐Barrett, Gregory W. Peet, et al.. (2004). Catalysis and Function of the p38α·MK2a Signaling Complex. Biochemistry. 43(31). 9950–9960. 47 indexed citations

11.

Davidson, Walter, Lee Frego, Gregory W. Peet, et al.. (2004). Discovery and Characterization of a Substrate Selective p38α Inhibitor. Biochemistry. 43(37). 11658–11671. 89 indexed citations

12.

Cywin, Charles L., Raymond A. Firestone, Daniel W. McNeil, et al.. (2003). The design of potent hydrazones and disulfides as cathepsin S inhibitors. Bioorganic & Medicinal Chemistry. 11(5). 733–740. 25 indexed citations

13.

Pullen, Steven S., Mark E. Labadia, Richard H. Ingraham, et al.. (1999). High-Affinity Interactions of Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) and CD40 Require TRAF Trimerization and CD40 Multimerization. Biochemistry. 38(31). 10168–10177. 128 indexed citations

14.

Labadia, Mark E., Deborah D. Jeanfavre, Gary Caviness, & Maurice M. Morelock. (1998). Molecular Regulation of the Interaction Between Leukocyte Function-Associated Antigen-1 and Soluble ICAM-1 by Divalent Metal Cations. The Journal of Immunology. 161(2). 836–842. 67 indexed citations

15.

Labadia, Mark E., Scott Jakes, Christine A. Grygon, et al.. (1997). Interaction between the SH2 Domains of ZAP-70 and the Tyrosine-Based Activation Motif 1 Sequence of the ζ Subunit of the T-Cell Receptor. Archives of Biochemistry and Biophysics. 342(1). 117–125. 15 indexed citations

16.

Labadia, Mark E., et al.. (1996). A synthetic peptide containing a predominant protein kinase C site within p47phox inhibits the NADPH oxidase in intact neutrophils. Journal of Leukocyte Biology. 59(1). 116–124. 15 indexed citations

17.

Labadia, Mark E., Ronald B. Faanes, & Robert Rothlein. (1990). Role of Adherence vs. Spreading in the Induction of Membrane-Associated Interleukin-1 on Mouse Peritoneal Macrophages. Journal of Leukocyte Biology. 48(5). 420–425. 10 indexed citations

18.

Merluzzi, Vincent J., Karl D. Hargrave, Mark E. Labadia, et al.. (1990). Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor. Science. 250(4986). 1411–1413. 653 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact